Delivery Order SPE2DX22D0010-SPE2D826FBC42
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $27,634.84 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 10, 2025, for completion by November 12, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $58,075.50 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 27, 2025, with an ultimate completion date of October 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle. The work will be performed at the company's corporate office location in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $18,548.60 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 7, 2025, with an ultimate completion date of November 10, 2025. This firm fixed price delivery order, issued without set-aside designation, represents a competitive award under AmerisourceBergen's existing indefinite delivery contract vehicle. The work will be performed at the company's corporate office in Conshohocken, Pennsylvania, where...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $9,727.92 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 15, 2025, with an ultimate completion date of October 16, 2025. This delivery order, issued under a firm fixed-price contract structure with no set-aside designation, represents a child contract action under AmerisourceBergen's larger indefinite delivery contract vehicle. The work will be performed at the vendor's corporate office...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $15,373.65 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 12, 2025, with an ultimate completion date of November 13, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger prime indefinite delivery contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $17,056.07 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at the contractor's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,318.50 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 24, 2025, with an ultimate completion date of October 27, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and is classified as a delivery order under a larger indefinite delivery contract vehicle. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $29,909.92 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed price delivery order, which was competitively awarded with no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $8,296.50 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 3, 2025, with an ultimate completion date of November 4, 2025. This firm fixed-price, competitively awarded delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract carries no...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $17,121.86 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle. The work will be performed at the company's corporate office location in...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FBC42Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $32,979.45 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle. The work is to be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's significant $999.99 billion indefinite delivery contract with DLA Troop Support Medical (designated SPE2DX) through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies a broad spectrum of pharmaceutical products and medical supplies to federal customers, including the Defense Health Agency and U.S. Coast Guard. The company's contract portfolio with DLA demonstrates its capability to deliver diverse medical commodities ranging from specialty medications and brand-name and generic drugs to vaccines and medical devices across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $33.0k | 11/17/25 |